首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Breaking the dependency cycle: A case report on successfully managed hemodialysis dependent chronic kidney disease with Ayurvedic treatment 打破依赖循环:阿育吠陀治疗成功管理血液透析依赖慢性肾脏疾病的病例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-14 DOI: 10.1016/j.jaim.2025.101177
Kaushal Patel , Kalapi Patel , Manish Patel , Chintan Bhatt , Mansi Patel
Chronic Kidney Disease (CKD) affects 13.4 % of the global population. Patients with End-Stage Renal Disease (ESRD) needing kidney transplant surgery are estimated between 4.902 and 7.083 million globally as of 2019 in India, which remains unaffordable for most of the population. This case study highlights a CKD G5 male patient undergoing hemodialysis weekly twice for two months, previously advised for transplant. The patient approached P D Patel Ayurveda Hospital, Nadiad, India, for treatment. Presented with puffiness on the face, breathlessness, muscle cramps, appetite loss, bilateral pedal edema, and occasional nausea and vomiting. Before Ayurvedic treatment, his serum creatinine level remained 12 mg/dL even with hemodialysis twice a week, which has been reduced up to 2.1 mg/dL, and blood urea reduced significantly, hemoglobin increased from 9.7 gms% to 14 gms%, and eGFR increased from 5 mL/min per 1.73 m2 to 34.8 mL/min per 1.73 m2. After the treatment, the patient is asymptomatic. This improvement is stable even after discontinuing all the medications except antihypertensive for two years. Following the treatment, dialysis was completely stopped, and the patient no longer required hemodialysis or a kidney transplant. This case provides new insight into the potential of traditional Ayurvedic treatments to manage advanced CKD, offering a cost-effective alternative to dialysis and transplantation.
慢性肾脏疾病(CKD)影响全球13.4%的人口。截至2019年,印度需要肾移植手术的终末期肾病(ESRD)患者估计在490.2万至708.3万之间,这对大多数人来说仍然是负担不起的。本病例研究突出了CKD G5男性患者,每周进行两次血液透析,持续两个月,先前建议移植。患者来到印度纳迪亚德的帕特尔阿育吠陀医院接受治疗。表现为面部浮肿、呼吸困难、肌肉痉挛、食欲减退、双侧足部水肿、偶有恶心和呕吐。在阿草药治疗前,即使每周进行两次血液透析,他的血清肌酐水平仍保持在12 mg/dL,已降至2.1 mg/dL,血尿素显著降低,血红蛋白从9.7 gms%增加到14 gms%, eGFR从5 mL/min / 1.73 m2增加到34.8 mL/min / 1.73 m2。治疗后,患者无症状。即使在停用除降压药外的所有药物两年后,这种改善仍然稳定。治疗后,透析完全停止,患者不再需要血液透析或肾移植。该病例为传统阿育吠陀疗法治疗晚期CKD的潜力提供了新的见解,为透析和移植提供了一种具有成本效益的替代方案。
{"title":"Breaking the dependency cycle: A case report on successfully managed hemodialysis dependent chronic kidney disease with Ayurvedic treatment","authors":"Kaushal Patel ,&nbsp;Kalapi Patel ,&nbsp;Manish Patel ,&nbsp;Chintan Bhatt ,&nbsp;Mansi Patel","doi":"10.1016/j.jaim.2025.101177","DOIUrl":"10.1016/j.jaim.2025.101177","url":null,"abstract":"<div><div>Chronic Kidney Disease (CKD) affects 13.4 % of the global population. Patients with End-Stage Renal Disease (ESRD) needing kidney transplant surgery are estimated between 4.902 and 7.083 million globally as of 2019 in India, which remains unaffordable for most of the population. This case study highlights a CKD G5 male patient undergoing hemodialysis weekly twice for two months, previously advised for transplant. The patient approached P D Patel Ayurveda Hospital, Nadiad, India, for treatment. Presented with puffiness on the face, breathlessness, muscle cramps, appetite loss, bilateral pedal edema, and occasional nausea and vomiting. Before Ayurvedic treatment, his serum creatinine level remained 12 mg/dL even with hemodialysis twice a week, which has been reduced up to 2.1 mg/dL, and blood urea reduced significantly, hemoglobin increased from 9.7 gms% to 14 gms%, and eGFR increased from 5 mL/min per 1.73 m<sup>2</sup> to 34.8 mL/min per 1.73 m<sup>2</sup>. After the treatment, the patient is asymptomatic. This improvement is stable even after discontinuing all the medications except antihypertensive for two years. Following the treatment, dialysis was completely stopped, and the patient no longer required hemodialysis or a kidney transplant. This case provides new insight into the potential of traditional Ayurvedic treatments to manage advanced CKD, offering a cost-effective alternative to dialysis and transplantation.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101177"},"PeriodicalIF":1.9,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145300847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basti treatment improved faecal calprotectin and faecal elastase of a patient of inflammatory bowel disease with sarcoidosis - a case report 巴斯提治疗可改善炎症性肠病伴结节病患者的粪便钙保护蛋白和粪便弹性蛋白酶。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-14 DOI: 10.1016/j.jaim.2025.101183
Ranjith Kumar kora, Praveen Kumar Madikonda, Bura Johar
Inflammatory Bowel Disease (IBD) and sarcoidosis are both chronic inflammatory disorders which in some rare instance can co-exist. The treatment with conventional medicines such as sulfasalazine, mesalamine, and steroids is challenge to patients and may not alleviate the disease completely. Ayurvedic treatments in this regard are often revolutionary and help in compressive management of all symptoms. We present a report of a 40-year-old male with IBD, diagnosed with sarcoidosis having abdominal pain, diarrhoea, and significant weight loss. Dadimadi Ghrita, Matra Basti and modified Piccha Basti were the line of treatment aimed at treating gastrointestinal inflammation and restoring normal bowel functions. The treatments improved the imbalance of Vata and Pitta doshas, that can effectively treat Pittadhik Vata Grahani. The effects of treatment was analysed by stool examination, weight gain and biomarkers useful to assess gastrointestinal health and disease (faecal calprotectin and faecal elastase).
炎症性肠病(IBD)和结节病都是慢性炎症性疾病,在一些罕见的情况下可以共存。常规药物如磺胺氮嗪、美沙拉胺和类固醇治疗对患者来说是一个挑战,可能不能完全缓解疾病。阿育吠陀治疗在这方面往往是革命性的,并有助于压缩管理的所有症状。我们报告了一位40岁男性IBD患者,诊断为结节病,腹痛,腹泻,体重明显下降。Dadimadi Ghrita, Matra Basti和改良的Piccha Basti是旨在治疗胃肠道炎症和恢复正常肠道功能的治疗方法。该治疗方法改善了Vata和Pitta能量的不平衡,可以有效地治疗Pittadhik Vata Grahani。通过粪便检查、体重增加和用于评估胃肠道健康和疾病的生物标志物(粪便钙保护蛋白和粪便弹性蛋白酶)来分析治疗效果。
{"title":"Basti treatment improved faecal calprotectin and faecal elastase of a patient of inflammatory bowel disease with sarcoidosis - a case report","authors":"Ranjith Kumar kora,&nbsp;Praveen Kumar Madikonda,&nbsp;Bura Johar","doi":"10.1016/j.jaim.2025.101183","DOIUrl":"10.1016/j.jaim.2025.101183","url":null,"abstract":"<div><div>Inflammatory Bowel Disease (IBD) and sarcoidosis are both chronic inflammatory disorders which in some rare instance can co-exist. The treatment with conventional medicines such as sulfasalazine, mesalamine, and steroids is challenge to patients and may not alleviate the disease completely. Ayurvedic treatments in this regard are often revolutionary and help in compressive management of all symptoms. We present a report of a 40-year-old male with IBD, diagnosed with sarcoidosis having abdominal pain, diarrhoea, and significant weight loss. <em>Dadimadi Ghrita, Matra Basti</em> and modified <em>Piccha Basti</em> were the line of treatment aimed at treating gastrointestinal inflammation and restoring normal bowel functions. The treatments improved the imbalance of <em>Vata</em> and <em>Pitta</em> doshas, that can effectively treat <em>Pittadhik Vata Grahani</em>. The effects of treatment was analysed by stool examination, weight gain and biomarkers useful to assess gastrointestinal health and disease (faecal calprotectin and faecal elastase).</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101183"},"PeriodicalIF":1.9,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145300811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of Haglund's deformity diagnosed as Vatakantaka - A case report 阿育吠陀治疗诊断为Vatakantaka的Haglund畸形1例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-13 DOI: 10.1016/j.jaim.2025.101185
Priyanka A. Dorage, Ashish A. Thatere, Rohini S. Prabhale
Haglund's deformity is one of the orthopedic problematic conditions manifest as a painful plantar heel. Haglund's deformity is a posterosuperior calcaneal projection of bony overgrowth from calcaneum bone which occurs when the foot is exposed to constant strain leading to calcium deposition in the heel bone, can be correlated with Vatakantaka in Ayurveda. It can be treated with a combination of Viddhakarma (therapeutic needle-piercing therapy), and Agnikarma (therapeutic heat therapy) with oral Ayurvedic medications which cure disease and provide long-term relief. A 48-year-old female came with complaints of difficulty in walking, pain in the left heel region which aggravates after awakening in the morning, standing long time, and after excessive walking. She had taken analgesics, and steroids drug for 8 months but didn't get relief. So, she opted for an Ayurvedic medication for further treatment. With the help of seven settings of Viddhakarma, and Agnikarma there was a significant improvement in clinical features, assessment scales of pain, function, swelling, tenderness, and in bony outgrowth. Viddhakarma and Agnikarma an easy, affordable, and straightforward techniques that may be carried out at the OPD level with basic facilities. It can be inferred from this case study that the Combination of Viddhakarma, Agnikarma with oral Ayurvedic drugs is an effective treatment modality for Haglund's deformity.
Haglund的畸形是矫形问题的条件之一,表现为足底后跟疼痛。Haglund畸形是跟骨过度生长的后上跟骨突出,当足部暴露在持续的压力下导致后跟骨钙沉积时发生,可与阿育吠陀中的Vatakantaka相关。它可以用Viddhakarma(治疗性针刺疗法)和Agnikarma(治疗性热疗法)结合口服阿育吠陀药物治疗疾病并提供长期缓解。患者48岁,女,主诉行走困难,左脚跟疼痛,早晨醒来、站立时间长、行走过度后疼痛加重。患者已服用镇痛药、类固醇药物8个月,但未见缓解。所以,她选择了阿育吠陀药物进行进一步治疗。在Viddhakarma和Agnikarma的七种设置的帮助下,临床特征、疼痛、功能、肿胀、压痛和骨生长的评估量表有了显着改善。Viddhakarma和Agnikarma是一种简单、负担得起的、直接的技术,可以在OPD级别使用基本设施进行。通过本案例研究可以推断,维达伽玛、阿格尼伽玛联合口服阿育吠陀药物是治疗Haglund畸形的有效方式。
{"title":"Ayurvedic management of Haglund's deformity diagnosed as Vatakantaka - A case report","authors":"Priyanka A. Dorage,&nbsp;Ashish A. Thatere,&nbsp;Rohini S. Prabhale","doi":"10.1016/j.jaim.2025.101185","DOIUrl":"10.1016/j.jaim.2025.101185","url":null,"abstract":"<div><div>Haglund's deformity is one of the orthopedic problematic conditions manifest as a painful plantar heel. Haglund's deformity is a posterosuperior calcaneal projection of bony overgrowth from calcaneum bone which occurs when the foot is exposed to constant strain leading to calcium deposition in the heel bone, can be correlated with <em>Vatakantaka</em> in Ayurveda. It can be treated with a combination of <em>Viddhakarma</em> (therapeutic needle-piercing therapy), and <em>Agnikarma</em> (therapeutic heat therapy) with oral Ayurvedic medications which cure disease and provide long-term relief. A 48-year-old female came with complaints of difficulty in walking, pain in the left heel region which aggravates after awakening in the morning, standing long time, and after excessive walking. She had taken analgesics, and steroids drug for 8 months but didn't get relief. So, she opted for an Ayurvedic medication for further treatment. With the help of seven settings of <em>Viddhakarma</em>, and <em>Agnikarma</em> there was a significant improvement in clinical features, assessment scales of pain, function, swelling, tenderness, and in bony outgrowth. <em>Viddhakarma</em> and <em>Agnikarma</em> an easy, affordable, and straightforward techniques that may be carried out at the OPD level with basic facilities. It can be inferred from this case study that the Combination of <em>Viddhakarma, Agnikarma</em> with oral Ayurvedic drugs is an effective treatment modality for Haglund's deformity.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101185"},"PeriodicalIF":1.9,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145292264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic conservative management of lumber disc disease with annular tear and radiculopathy leading to complete clinical recovery - A case report 阿育吠陀保守治疗腰椎间盘疾病伴环撕裂和神经根病导致临床完全恢复- 1例报告
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-11 DOI: 10.1016/j.jaim.2025.101205
Sanjeev Rastogi , Krishna Gopal Sharma
Lower back pain radiating down to lower limbs has been a common clinical entity. This is one prominent reason for absenteeism from workplace leading to loss of work hours and reduced productivity. It is often treated symptomatically and warrants for a disc related surgery if alarming signs pertaining to compressive neuropathy prompt so. Conservative management from Ayurveda is seen to offer good responses in cases where severe locomotor debility persists and warrants for spinal surgery. A young girl diagnosed for lumber spine annular tear and radiculopathy through MRI and having Oswestry Disability Index (ODI) 66 % corresponding to severe disability was treated through whole system Ayurveda management for one year and recovered completely. This case report proposes that Ayurveda whole system management in cases of prolapse intervertebral disc disease with radiculopathy can provide a sustained clinical relief also reflected through radiological investigations.
腰痛向下肢放射是一种常见的临床症状。这是旷工导致工作时间损失和生产力降低的一个突出原因。它通常是对症治疗和保证椎间盘相关手术,如果报警迹象有关的压迫性神经病变提示。阿育吠陀的保守治疗被认为在严重的运动能力持续下降并需要脊柱手术的情况下提供了良好的反应。一个年轻的女孩,通过MRI诊断为腰椎环撕裂和神经根病,Oswestry残疾指数(ODI)为66%,对应严重残疾,通过全系统阿育吠陀治疗一年,完全康复。本病例报告提出,阿育吠陀全系统管理在腰椎间盘突出症合并神经根病的病例中可以提供持续的临床缓解,这也通过影像学检查反映出来。
{"title":"Ayurvedic conservative management of lumber disc disease with annular tear and radiculopathy leading to complete clinical recovery - A case report","authors":"Sanjeev Rastogi ,&nbsp;Krishna Gopal Sharma","doi":"10.1016/j.jaim.2025.101205","DOIUrl":"10.1016/j.jaim.2025.101205","url":null,"abstract":"<div><div>Lower back pain radiating down to lower limbs has been a common clinical entity. This is one prominent reason for absenteeism from workplace leading to loss of work hours and reduced productivity. It is often treated symptomatically and warrants for a disc related surgery if alarming signs pertaining to compressive neuropathy prompt so. Conservative management from Ayurveda is seen to offer good responses in cases where severe locomotor debility persists and warrants for spinal surgery. A young girl diagnosed for lumber spine annular tear and radiculopathy through MRI and having Oswestry Disability Index (ODI) 66 % corresponding to severe disability was treated through whole system Ayurveda management for one year and recovered completely. This case report proposes that Ayurveda whole system management in cases of prolapse intervertebral disc disease with radiculopathy can provide a sustained clinical relief also reflected through radiological investigations.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101205"},"PeriodicalIF":1.9,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145269962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of persistent ulcers after snakebite – A case report 蛇咬伤后持续性溃疡的阿育吠陀治疗- 1例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-11 DOI: 10.1016/j.jaim.2025.101228
Sandesh Kumar, Sukanya Bhat
Snake bites pose a major public health challenge worldwide, with significant morbidity and mortality. Non-healing ulcers are common in snakebite survivors, often resulting in chronic pain, infection, necrosis, and, in severe cases, amputation. This case study discusses the Ayurvedic treatment of a non-healing ulcer following a viper bite in a 63-year-old woman. The treatment protocol included Vrana Prakshalana (ulcer washing), Pariseka (irrigation), and Bandha (bandaging) with medicated oils and pastes, along with oral traditional formulations like Gandhaka Rasayana and Mahamanjishtadi kashaya. Over four months, the patient experienced complete ulcer healing, pain reduction, and resolution of edema, illustrating the effectiveness of Ayurvedic therapies in addressing complex post-snakebite complications and preventing further issues. This case underscores Ayurveda's potential in managing chronic, treatment-resistant wounds.
蛇咬伤是世界范围内一个重大的公共卫生挑战,发病率和死亡率都很高。无法愈合的溃疡在蛇咬伤幸存者中很常见,通常会导致慢性疼痛、感染、坏死,在严重的情况下,会导致截肢。本案例研究讨论了阿育吠陀治疗毒蛇咬伤后不愈合溃疡的63岁妇女。治疗方案包括Vrana Prakshalana(溃疡清洗)、Pariseka(灌溉)和Bandha(包扎),以及Gandhaka Rasayana和Mahamanjishtadi kashaya等口服传统配方。四个多月后,患者溃疡完全愈合,疼痛减轻,水肿消退,说明阿育吠陀疗法在解决蛇咬伤后复杂并发症和预防进一步问题方面的有效性。这个案例强调了阿育吠陀在治疗慢性、治疗抵抗性伤口方面的潜力。
{"title":"Ayurvedic management of persistent ulcers after snakebite – A case report","authors":"Sandesh Kumar,&nbsp;Sukanya Bhat","doi":"10.1016/j.jaim.2025.101228","DOIUrl":"10.1016/j.jaim.2025.101228","url":null,"abstract":"<div><div>Snake bites pose a major public health challenge worldwide, with significant morbidity and mortality. Non-healing ulcers are common in snakebite survivors, often resulting in chronic pain, infection, necrosis, and, in severe cases, amputation. This case study discusses the Ayurvedic treatment of a non-healing ulcer following a viper bite in a 63-year-old woman. The treatment protocol included <em>Vrana Prakshalana</em> (ulcer washing), <em>Pariseka</em> (irrigation), and <em>Bandha</em> (bandaging) with medicated oils and pastes, along with oral traditional formulations like <em>Gandhaka Rasayana</em> and <em>Mahamanjishtadi kashaya</em>. Over four months, the patient experienced complete ulcer healing, pain reduction, and resolution of edema, illustrating the effectiveness of Ayurvedic therapies in addressing complex post-snakebite complications and preventing further issues. This case underscores Ayurveda's potential in managing chronic, treatment-resistant wounds.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101228"},"PeriodicalIF":1.9,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145279943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A holistic Ayurvedic approach to manage persistent depressive disorder, Vishada—A case report 一个整体的阿育吠陀方法来管理持续性抑郁症,维沙达-一个案例报告
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-27 DOI: 10.1016/j.jaim.2025.101243
Aqsa Zarin Khan , Jibi Varghese , Chandrakumar Deshmukh , Prashant Khade , Sana Khanam Mirza , Manna Mathew
Persistent Depressive Disorder (PDD), formerly known as Dysthymia, is a chronic and enduring form of depression. In contemporary society, the pressures of modern lifestyles, pervasive feelings of uncertainty and insecurity, the fast pace of life, competition in various domains, suboptimal hygiene practices, and food adulteration have become primary contributors to the disruption of mental and physical well-being. Persistent Depressive Disorder (PDD) can be correlated to Vishada in Ayurveda. This article presents a case study of a patient diagnosed with PDD (Persistent Depressive Disorder) as per DSM-5 criteria. Management was planned with integrative treatment consisting of Sattvavajaya chikitsa (Ayurveda psychotherapy), Shamana Chikitsa (oral medicines), and the skillful implementation of Viddhakarma, thus illustrating its efficacy in depression. The treatment persisted for six months, and the intervention outcome demonstrated a decrease in Hamilton Depression Rating scores, declining from 16 to 5 with a reduction of symptoms by the end of the six months of intervention. Viddhakarma, one among the eight shastra karma, is regarded as one of the most effective para-surgical procedures for regulating the vitiated dosha described by Acharya Shushrut and Acharya Vagbhata. This article is a sincere effort to emphasize the significance and application of Viddhakarma therapy along with the conventional Ayurveda treatment in manasik vikaras. Furthermore, the observed improvements were sustained even throughout the non-interventional observation period.
持续性抑郁症(PDD),以前被称为心境恶劣,是一种慢性和持久的抑郁症。在当代社会,现代生活方式的压力、普遍的不确定感和不安全感、快节奏的生活、各个领域的竞争、不理想的卫生习惯和食品掺假已成为破坏身心健康的主要因素。持续性抑郁障碍(PDD)可能与阿育吠陀中的毗沙达相关。这篇文章提出了一个病例研究的病人诊断为PDD(持续性抑郁症),根据DSM-5标准。管理计划采用综合治疗,包括Sattvavajaya chikitsa(阿育吠陀心理治疗),Shamana chikitsa(口服药物)和熟练实施Viddhakarma,从而说明其对抑郁症的疗效。治疗持续了六个月,干预结果显示汉密尔顿抑郁评分下降,从16分下降到5分,六个月干预结束时症状减轻。Viddhakarma是八业之一,被认为是最有效的准外科手术之一,可以调节《阿查里亚·舒什鲁》和《阿查里亚·Vagbhata》所描述的被破坏的状态。这篇文章是一个真诚的努力,强调Viddhakarma疗法的意义和应用,以及传统的阿育吠陀治疗在马纳西克维卡拉。此外,观察到的改善甚至在整个非干预观察期都持续存在。
{"title":"A holistic Ayurvedic approach to manage persistent depressive disorder, Vishada—A case report","authors":"Aqsa Zarin Khan ,&nbsp;Jibi Varghese ,&nbsp;Chandrakumar Deshmukh ,&nbsp;Prashant Khade ,&nbsp;Sana Khanam Mirza ,&nbsp;Manna Mathew","doi":"10.1016/j.jaim.2025.101243","DOIUrl":"10.1016/j.jaim.2025.101243","url":null,"abstract":"<div><div>Persistent Depressive Disorder (PDD), formerly known as Dysthymia, is a chronic and enduring form of depression. In contemporary society, the pressures of modern lifestyles, pervasive feelings of uncertainty and insecurity, the fast pace of life, competition in various domains, suboptimal hygiene practices, and food adulteration have become primary contributors to the disruption of mental and physical well-being. Persistent Depressive Disorder (PDD) can be correlated to <em>Vishada</em> in Ayurveda. This article presents a case study of a patient diagnosed with PDD (Persistent Depressive Disorder) as per DSM-5 criteria. Management was planned with integrative treatment consisting of <em>Sattvavajaya chikitsa</em> (Ayurveda psychotherapy), <em>Shamana Chikitsa</em> (oral medicines), and the skillful implementation of <em>Viddhakarma,</em> thus illustrating its efficacy in depression. The treatment persisted for six months, and the intervention outcome demonstrated a decrease in Hamilton Depression Rating scores, declining from 16 to 5 with a reduction of symptoms by the end of the six months of intervention. <em>Viddhakarma</em>, one among the eight <em>shastra karma</em>, is regarded as one of the most effective para-surgical procedures for regulating the vitiated <em>dosha</em> described by <em>Acharya</em> Shushrut and <em>Acharya</em> Vagbhata. This article is a sincere effort to emphasize the significance and application of <em>Viddhakarma</em> therapy along with the conventional Ayurveda treatment in <em>manasik vikaras</em>. Furthermore, the observed improvements were sustained even throughout the non-interventional observation period.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101243"},"PeriodicalIF":1.9,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating macro-microscopy, DNA barcoding and HPTLC for quality assessment of berberine containing botanicals traded as Maramanjal/Daruharidra 结合宏观显微镜、DNA条形码和HPTLC技术对以Maramanjal/Daruharidra交易的含有小檗碱的植物药进行质量评价
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.jaim.2025.101192
Sunil Kumar Koppala Narayana , Pushkar Kaira , Mahima Karthikeyan , Murugammal Shanmugam , Susikumar Sundharamoorthy , Remya Andalil , Divya Kallingil Gopi , Radha Prakasam , Shakila Ramachandran , Kanagarajan Arumugam

Background

Daruharidra/Maramanjal is one of the most popular shrub used in Ayurveda, Siddha and other Indian medicinal systems. More than one botanical source is traded under this name, predominantly Berberis aristata and Coscinium fenestratum with an annual trade of 1000–2000 metric tonnes. The herbal drug trade is often reported with misidentification, adulteration and/or substitution issues due to morphological resemblance and confusion in vernacular names. This work aimed to integrate macro-microscopic, DNA marker strategies and phytochemical assay to differentiate Berberis aristata from its traded sources.

Material and methods

Thirteen marketed samples and one authentic field sample from natural habitat were collected from various regions of the Indian market under the trade name Maramanjal/Daruharidra. The traditional identification methods included macro-microscopic and phytochemical screening by High-Performance Thin Layer Chromatography (HPTLC). Additionally, DNA barcode-based molecular identification and phylogenetic analysis were done using the ITS2 (Internal Transcribed Spacer 2) marker.

Results

The macroscopic observations revealed 80 % ad-mixing of various allied botanicals in addition to accepted north Indian and south Indian sources such as B. aristata and C. fenestratum respectively. DNA barcoding enabled the identification of genuine and adulterated raw drugs from the collected samples. The HPTLC quantification revealed the presence of berberine in all 14 samples varying from 1.12 % to 26.33 %.

Conclusions

The macro-micro, HPTLC, and DNA barcoding helped in the identification of adulteration and substitution practices in this highly traded botanical drug. DNA barcoding can prove an effective tool for discovering the adulteration and substitution of Maramanjal/Daruharidra and this is its first report on the application of morphology, microscopy, phytochemical analysis, and DNA markers in differentiating these traded species.
daruharidra /Maramanjal是阿育吠陀、悉达和其他印度医疗系统中最受欢迎的灌木之一。以这个名字进行交易的植物来源不止一种,主要是小檗(Berberis aristata)和黄连木(coscium fenestratum),年交易量为1000-2000公吨。由于形态相似和白话名称混淆,草药贸易经常报告有误认、掺假和/或替代问题。本研究旨在整合宏观显微镜、DNA标记策略和植物化学分析方法来区分马兜铃小檗及其贸易来源。材料和方法从印度市场的不同地区以商品名Maramanjal/Daruharidra收集了13个市场样本和一个来自自然栖息地的真实实地样本。传统的鉴定方法包括宏观显微镜和高效薄层色谱(HPTLC)筛选。此外,利用ITS2 (Internal transcripsed Spacer 2)标记进行了基于DNA条形码的分子鉴定和系统发育分析。结果宏观观察结果显示,除了印度北部的马兜铃和印度南部的凤尾草等公认的植物来源外,还有80%的植物混合在一起。DNA条形码能够从收集的样品中识别真假原料药。hplc定量分析显示,14份样品中小檗碱的含量在1.12% ~ 26.33%之间。结论宏微观、HPTLC和DNA条形码技术有助于鉴别该药材的掺假和替代行为。DNA条形码可以证明是一种有效的工具,用于发现掺假和替代的Maramanjal/Daruharidra,这是其首次应用形态学,显微镜,植物化学分析和DNA标记来区分这些交易物种。
{"title":"Integrating macro-microscopy, DNA barcoding and HPTLC for quality assessment of berberine containing botanicals traded as Maramanjal/Daruharidra","authors":"Sunil Kumar Koppala Narayana ,&nbsp;Pushkar Kaira ,&nbsp;Mahima Karthikeyan ,&nbsp;Murugammal Shanmugam ,&nbsp;Susikumar Sundharamoorthy ,&nbsp;Remya Andalil ,&nbsp;Divya Kallingil Gopi ,&nbsp;Radha Prakasam ,&nbsp;Shakila Ramachandran ,&nbsp;Kanagarajan Arumugam","doi":"10.1016/j.jaim.2025.101192","DOIUrl":"10.1016/j.jaim.2025.101192","url":null,"abstract":"<div><h3>Background</h3><div><em>Daruharidra/Maramanjal</em> is one of the most popular shrub used in Ayurveda, Siddha and other Indian medicinal systems. More than one botanical source is traded under this name, predominantly <em>Berberis aristata</em> and <em>Coscinium fenestratum</em> with an annual trade of 1000–2000 metric tonnes. The herbal drug trade is often reported with misidentification, adulteration and/or substitution issues due to morphological resemblance and confusion in vernacular names. This work aimed to integrate macro-microscopic, DNA marker strategies and phytochemical assay to differentiate <em>Berberis aristata</em> from its traded sources.</div></div><div><h3>Material and methods</h3><div>Thirteen marketed samples and one authentic field sample from natural habitat were collected from various regions of the Indian market under the trade name <em>Maramanjal/Daruharidra</em>. The traditional identification methods included macro-microscopic and phytochemical screening by High-Performance Thin Layer Chromatography (HPTLC). Additionally, DNA barcode-based molecular identification and phylogenetic analysis were done using the ITS2 (Internal Transcribed Spacer 2) marker.</div></div><div><h3>Results</h3><div>The macroscopic observations revealed 80 % ad-mixing of various allied botanicals in addition to accepted north Indian and south Indian sources such as <em>B. aristata</em> and <em>C. fenestratum</em> respectively. DNA barcoding enabled the identification of genuine and adulterated raw drugs from the collected samples. The HPTLC quantification revealed the presence of berberine in all 14 samples varying from 1.12 % to 26.33 %.</div></div><div><h3>Conclusions</h3><div>The macro-micro, HPTLC, and DNA barcoding helped in the identification of adulteration and substitution practices in this highly traded botanical drug. DNA barcoding can prove an effective tool for discovering the adulteration and substitution of <em>Maramanjal/Daruharidra</em> and this is its first report on the application of morphology, microscopy, phytochemical analysis, and DNA markers in differentiating these traded species.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101192"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pedagogy experiments for Ayush academia 阿尤什学术界的教育学实验。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.jaim.2025.101273
Girish Tillu
{"title":"Pedagogy experiments for Ayush academia","authors":"Girish Tillu","doi":"10.1016/j.jaim.2025.101273","DOIUrl":"10.1016/j.jaim.2025.101273","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101273"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of yoga on pulmonary functions in clinical population: A systematic review and meta-analysis of randomized controlled trials (RCTs) 瑜伽对临床人群肺功能的影响:随机对照试验(rct)的系统回顾和荟萃分析
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.jaim.2025.101189
Vipin K. Rathore, Sandeep Singh, Nidheesh Yadav
This study aims to investigate the impact of yoga practice on pulmonary and respiratory functions in clinical populations. A thorough search was carried out in the Cochrane Library, PubMed, Science Direct databases, and Google Scholar, using the keywords “Yog∗” and “pulmonary functions”, covering the period from January 2010 to December 2022. Studies that aligned with PRISMA recommendations were included. The Cochrane risk-assessment tool was employed to assess bias risk. We calculated weighted mean differences (WMDs) with 95 % confidence intervals (CIs) and used the I2 test to assess heterogeneity. Initially, 529 studies were found through the search, with 10 randomized controlled trials (RCTs) involving 1007 patients meeting the inclusion criteria for quality assessment and meta-analysis. The results indicated that yoga intervention (YI) significantly improved FVC% (WMD: 3.03 L, 95 % CI: 1.71, 4.35, P < 0.00001), FEV1 (WMD: 0.47 L, 95 % CI: 0.43, 0.51, P < 0.00001), and FEV1% (WMD: 5.74 L, 95 % CI: 4.47, 7.01, P < 0.00001) when compared to control groups. However, no significant effect was observed on FVC (WMD: 0.23 L, CI: 0.16, 0.62. P = 0.25), PEFR (WMD: 0.49, CI: 0.70, 1.67, P = 0.42), MVV (WMD: 9.01, CI: 3.92, 21.94, P = 0.17), and FEV1/FVC (WMD: 3.17, CI: 1.15, 7.48, P = 0.15) as a result of YI. Based on the limited evidence and meta-analysis conducted, YI demonstrated a positive effect on pulmonary function in clinical populations and could be considered as an adjunct therapy for individuals with various respiratory diseases. Further rigorous research with larger sample sizes is necessary to confirm the long-term benefits of yoga.
本研究旨在探讨瑜伽练习对临床人群肺和呼吸功能的影响。在Cochrane图书馆、PubMed、Science Direct数据库和谷歌Scholar中进行了彻底的搜索,使用关键词“yoga *”和“肺功能”,涵盖了2010年1月至2022年12月的时间。纳入了符合PRISMA建议的研究。采用Cochrane风险评估工具评估偏倚风险。我们以95%置信区间(ci)计算加权平均差异(wmd),并使用I2检验评估异质性。最初,通过搜索发现了529项研究,其中10项随机对照试验(rct)涉及1007名患者,符合质量评估和荟萃分析的纳入标准。结果表明,与对照组相比,瑜伽干预(YI)显著改善了FVC% (WMD: 3.03 L, 95% CI: 1.71, 4.35, P < 0.00001)、FEV1 (WMD: 0.47 L, 95% CI: 0.43, 0.51, P < 0.00001)和FEV1% (WMD: 5.74 L, 95% CI: 4.47, 7.01, P < 0.00001)。但对植被覆盖度无显著影响(WMD: 0.23 L, CI: 0.16, 0.62)。P = 0.25),病人(CI大规模杀伤性武器:0.49:0.70,1.67,P = 0.42), MVV (CI大规模杀伤性武器:9.01:3.92,21.94,P = 0.17),和FEV1 / FVC的(大规模杀伤性武器:3.17,CI: 1.15, 7.48, P = 0.15)由于易建联。基于有限的证据和荟萃分析,在临床人群中,YI显示出对肺功能的积极作用,可以考虑作为各种呼吸系统疾病患者的辅助治疗。为了证实瑜伽的长期益处,有必要进行更大规模的严格研究。
{"title":"Impact of yoga on pulmonary functions in clinical population: A systematic review and meta-analysis of randomized controlled trials (RCTs)","authors":"Vipin K. Rathore,&nbsp;Sandeep Singh,&nbsp;Nidheesh Yadav","doi":"10.1016/j.jaim.2025.101189","DOIUrl":"10.1016/j.jaim.2025.101189","url":null,"abstract":"<div><div>This study aims to investigate the impact of yoga practice on pulmonary and respiratory functions in clinical populations. A thorough search was carried out in the Cochrane Library, PubMed, Science Direct databases, and Google Scholar, using the keywords “Yog∗” and “pulmonary functions”, covering the period from January 2010 to December 2022. Studies that aligned with PRISMA recommendations were included. The Cochrane risk-assessment tool was employed to assess bias risk. We calculated weighted mean differences (WMDs) with 95 % confidence intervals (CIs) and used the I<sup>2</sup> test to assess heterogeneity. Initially, 529 studies were found through the search, with 10 randomized controlled trials (RCTs) involving 1007 patients meeting the inclusion criteria for quality assessment and meta-analysis. The results indicated that yoga intervention (YI) significantly improved FVC% (WMD: 3.03 L, 95 % CI: 1.71, 4.35, P &lt; 0.00001), FEV1 (WMD: 0.47 L, 95 % CI: 0.43, 0.51, P &lt; 0.00001), and FEV1% (WMD: 5.74 L, 95 % CI: 4.47, 7.01, P &lt; 0.00001) when compared to control groups. However, no significant effect was observed on FVC (WMD: 0.23 L, CI: 0.16, 0.62. P = 0.25), PEFR (WMD: 0.49, CI: 0.70, 1.67, P = 0.42), MVV (WMD: 9.01, CI: 3.92, 21.94, P = 0.17), and FEV1/FVC (WMD: 3.17, CI: 1.15, 7.48, P = 0.15) as a result of YI. Based on the limited evidence and meta-analysis conducted, YI demonstrated a positive effect on pulmonary function in clinical populations and could be considered as an adjunct therapy for individuals with various respiratory diseases. Further rigorous research with larger sample sizes is necessary to confirm the long-term benefits of yoga.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101189"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144996896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report on Ayurvedic management of progressive bulbar palsy-A rare amyotrophic lateral sclerosis phenotype 阿育吠陀治疗进行性球性麻痹1例报告-罕见的肌萎缩性侧索硬化表型
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.jaim.2025.101176
Sinimol Thekkekkoottumughath Peethambaran , Abhayadev Ashokan , Varanasi Subhose
This case report is the description of a devastating illness, Progressive Bulbar Palsy (PBP) of a sixty-seven years old male patient. He presented with complaints of slurred speech, hearing impairment, generalised weakness of limbs, weakened grip to hold objects in hand, difficulty to walk with normal speed, frequent dizzy feeling while walking, severe fatigue, increased anger, heaviness of head, depression, anxiety, decreased memory and headache for 1 year. When he consulted conventional medicine, in Magnetic Resonance Imaging (MRI) of brain, only ‘Partial empty sella’ and age related mild cerebral atrophy was detected and the patient was diagnosed PBP clinically. They prescribed Riluzole 50 mg tablet twice a day and Fluoxetine 10mg capsules at night time for 3 months, but obtained no relief for symptoms and consulted this Out Patient Department (OPD). In Ayurvedic parlance, PBP resembles conditions like Kaphavruta vata. In this patient, Pittavritavata symptoms like bhrama (∼dizziness) was also present in increased severity. Diagnosis was done with the aid of Gold Coast diagnostic criteria. Internal and external medications with properties alleviating avarana (∼occlusion) of vata by kapha and pitta, shodhana (∼expelling the aggravated doshas and cleanses the body internally), rejuvenating (Rasayana) properties, for overall strengthening of nervous system and musculoskeletal system, enhancing balance and coordination, improving speech and memory were used. The assessment was done before and after the treatment by ‘Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The score before and after the treatment was 35 and 45 respectively out of 48. The treatment helped to increase the quality of life exceptionally as symptomatic relief was obtained. As it is a devastating disorder with poor prognosis and most probably will lead to death, it is advisable to repeat the treatments in regular intervals, depending on the recurrence of symptoms, if any.
本病例报告是一个毁灭性的疾病,进行性球麻痹(PBP)的67岁男性患者的描述。其主诉为言语不清、听力障碍、四肢全身性无力、握物能力减弱、正常速度行走困难、行走时常感到头晕、严重疲劳、易怒、头重、抑郁、焦虑、记忆力下降、头痛1年。经常规医学检查,脑磁共振成像(MRI)仅检出“部分鞍区空”及年龄相关性轻度脑萎缩,临床诊断为PBP。服用利鲁唑50 mg片剂,每日2次,氟西汀10mg胶囊,夜间1次,疗程3个月,症状未见缓解,就诊于门诊。在阿育吠陀的说法中,PBP类似于Kaphavruta vata。在该患者中,皮塔夫里塔塔症状如bhrama(~头晕)也出现,且严重程度增加。根据黄金海岸诊断标准进行诊断。使用具有减轻kapha和pitta对vata的avarana(~阻断),shodhana(~排出加重的dosha并在内部清洁身体),恢复活力(Rasayana)特性的内部和外部药物,以全面加强神经系统和肌肉骨骼系统,增强平衡和协调,改善语言和记忆。在治疗前后采用“肌萎缩侧索硬化症功能评定量表-修订版(ALSFRS-R)”进行评估。治疗前后分别为35分和45分(总分48分)。治疗有助于提高生活质量,特别是获得症状缓解。由于这是一种预后不良且极有可能导致死亡的毁灭性疾病,建议根据症状的复发情况(如果有的话)定期重复治疗。
{"title":"A case report on Ayurvedic management of progressive bulbar palsy-A rare amyotrophic lateral sclerosis phenotype","authors":"Sinimol Thekkekkoottumughath Peethambaran ,&nbsp;Abhayadev Ashokan ,&nbsp;Varanasi Subhose","doi":"10.1016/j.jaim.2025.101176","DOIUrl":"10.1016/j.jaim.2025.101176","url":null,"abstract":"<div><div>This case report is the description of a devastating illness, Progressive Bulbar Palsy (PBP) of a sixty-seven years old male patient. He presented with complaints of slurred speech, hearing impairment, generalised weakness of limbs, weakened grip to hold objects in hand, difficulty to walk with normal speed, frequent dizzy feeling while walking, severe fatigue, increased anger, heaviness of head, depression, anxiety, decreased memory and headache for 1 year. When he consulted conventional medicine, in Magnetic Resonance Imaging (MRI) of brain, only ‘Partial empty sella’ and age related mild cerebral atrophy was detected and the patient was diagnosed PBP clinically. They prescribed Riluzole 50 mg tablet twice a day and Fluoxetine 10mg capsules at night time for 3 months, but obtained no relief for symptoms and consulted this Out Patient Department (OPD). In Ayurvedic parlance, PBP resembles conditions like <em>Kaphavruta vata</em>. In this patient, <em>Pittavritavata</em> symptoms like <em>bhrama</em> (∼dizziness) was also present in increased severity. Diagnosis was done with the aid of Gold Coast diagnostic criteria. Internal and external medications with properties alleviating <em>avarana</em> (∼occlusion) of <em>vata</em> by <em>kapha</em> and <em>pitta</em>, <em>shodhana</em> (∼expelling the aggravated doshas and cleanses the body internally), rejuvenating <em>(Rasayana) properties,</em> for overall strengthening of nervous system and musculoskeletal system, enhancing balance and coordination, improving speech and memory were used. The assessment was done before and after the treatment by ‘Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The score before and after the treatment was 35 and 45 respectively out of 48. The treatment helped to increase the quality of life exceptionally as symptomatic relief was obtained. As it is a devastating disorder with poor prognosis and most probably will lead to death, it is advisable to repeat the treatments in regular intervals, depending on the recurrence of symptoms, if any.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101176"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144996897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1